{"DataElement":{"publicId":"7429602","version":"1","preferredName":"Disease Staging System","preferredDefinition":"The name of the staging system used in the evaluation of the disease.","longName":"DZSTAGE_SYS","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7429520","version":"1","preferredName":"Tumor Results Domain Disease or Disorder Staging System","preferredDefinition":"A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors identified in the TU domain._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A systematic method for clinicopathologic evaluation of tumors.","longName":"6607916v1.0:7429518v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6607916","version":"1","preferredName":"Tumor Results Domain","preferredDefinition":"A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors identified in the TU domain.","longName":"C106578","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Results Domain","conceptCode":"C106578","definition":"A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors identified in the TU domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1E2044-4BDC-76E5-E053-F662850A745A","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7429518","version":"1","preferredName":"Disease or Disorder Staging System","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A systematic method for clinicopathologic evaluation of tumors.","longName":"C2991:C18004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Staging System","conceptCode":"C18004","definition":"A systematic method for clinicopathologic evaluation of tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFECB23C-7383-298A-E053-4EBD850A69A3","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFECB23C-7394-298A-E053-4EBD850A69A3","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"TAYLORT","dateModified":"2020-09-25","changeDescription":"NCICOVID NSV; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7429556","version":"1","preferredName":"Disease Staging System Name","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A systematic method for clinicopathologic evaluation of tumors._The words or language units by which a thing is known.","longName":"DZSTAGE_SYS_NAME","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"AMERICAN JOINT COMMITTEE ON CANCER (AJCC)","valueDescription":"American Joint Committee on Cancer","ValueMeaning":{"publicId":"2647206","version":"1","preferredName":"American Joint Committee on Cancer","longName":"2647206","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"322D8245-A231-0462-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFED7454-F5D3-23FF-E053-4EBD850A6220","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFFABC71-9174-32E8-E053-4EBD850A548E","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","deletedIndicator":"No"},{"value":"INTERNATIONAL STAGING SYSTEM (ISS","valueDescription":"Plasma Cell Myeloma by ISS Stage","ValueMeaning":{"publicId":"7430994","version":"1","preferredName":"Plasma Cell Myeloma by ISS Stage","longName":"7430994","preferredDefinition":"A header term that refers to the staging of plasma cell myeloma according to the International Staging System.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma by ISS Stage","conceptCode":"C139009","definition":"A header term that refers to the staging of multiple myeloma according to the International Staging System.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFFA9B72-BA39-32EA-E053-4EBD850A8048","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"TAYLORT","dateModified":"2020-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFFA9B72-BA52-32EA-E053-4EBD850A8048","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","deletedIndicator":"No"},{"value":"RAI STAGING SYSTEM","valueDescription":"Rai Staging System","ValueMeaning":{"publicId":"7430995","version":"1","preferredName":"Rai Staging System","longName":"7430995","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.  (from OncoLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rai Staging System","conceptCode":"C20115","definition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.  (from OncoLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFFA9B72-BA5E-32EA-E053-4EBD850A8048","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFFA9B72-BA79-32EA-E053-4EBD850A8048","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","deletedIndicator":"No"},{"value":"REVISED INTERNATIONAL STAGING SYSTEM (R-ISS)","valueDescription":"Plasma Cell Myeloma by RISS Stage","ValueMeaning":{"publicId":"7430997","version":"1","preferredName":"Plasma Cell Myeloma by RISS Stage","longName":"7430997","preferredDefinition":"A staging system for plasma cell myeloma based on the Revised International Staging System (RISS) criteria. This staging system does not apply to smoldering multiple myeloma (no AJCC staging system), monoclonal gammopathy of undetermined significance (no AJCC staging system), and Waldenstrom macroglobulinemia (no AJCC staging system). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma by RISS Stage","conceptCode":"C141393","definition":"A staging system for multiple myeloma based on the Revised International Staging System (RISS) criteria. This staging system does not apply to smoldering multiple myeloma (no AJCC staging system), monoclonal gammopathy of undetermined significance (no AJCC staging system), and Waldenstrom macroglobulinemia (no AJCC staging system). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFFA9B72-BA86-32EA-E053-4EBD850A8048","latestVersionIndicator":"Yes","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFFA9B72-BAA1-32EA-E053-4EBD850A8048","beginDate":"2020-09-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-23","modifiedBy":"ONEDATA","dateModified":"2020-09-23","deletedIndicator":"No"},{"value":"AIDS CLINICAL TRIALS GROUP (ACTG) STAGING CRITERIA FOR KAPOSI SARCOMA","valueDescription":null,"ValueMeaning":{"publicId":"14630890","version":"1","preferredName":"AIDS Clinical Trials Group (ACTG) Staging Criteria for Kaposi Sarcoma","longName":"14630890v1.00","preferredDefinition":"AIDS Clinical Trials Group (ACTG) Staging Criteria for Kaposi Sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B4E81F5-3AD2-3896-E063-731AD00A95C3","latestVersionIndicator":"Yes","beginDate":"2023-11-29","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-29","modifiedBy":"GDEEN","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4E81F5-3AD3-3896-E063-731AD00A95C3","beginDate":"2023-11-29","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-29","modifiedBy":"GDEEN","dateModified":"2023-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7429555","version":"1","preferredName":"Disease or Disorder Staging System Name","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:A systematic method for clinicopathologic evaluation of tumors.:The words or language units by which a thing is known.","longName":"C2991:C18004:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Staging System","conceptCode":"C18004","definition":"A systematic method for clinicopathologic evaluation of tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFED7454-F5A0-23FF-E053-4EBD850A6220","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFED7454-F5B1-23FF-E053-4EBD850A6220","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"GDEEN","dateModified":"2023-11-29","changeDescription":"NCICOVID; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"},{"publicId":"3308730","version":"1","longName":"MediData Rave Use","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Staging System","type":"Preferred Question Text","description":"Staging System","url":null,"context":"Theradex"},{"name":"CCR Text 1","type":"Alternate Question Text","description":"How Measured","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFED5C50-33F2-29DF-E053-4EBD850AE728","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"GDEEN","dateModified":"2023-11-29","changeDescription":"NCICOVID NSV; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}